Literature DB >> 2947981

Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats.

D Vergé, G Daval, M Marcinkiewicz, A Patey, S el Mestikawy, H Gozlan, M Hamon.   

Abstract

The distribution of the 2 main types (A and B) of 5-HT1 binding sites in the rat brain was studied by light-microscopic quantitative autoradiography. The 5-HT1A sites were identified using 3H-8-hydroxy-2-(N-dipropylamino)tetralin (3H-8-OH-DPAT) or 3H-5-HT as the ligand. In the latter case, it was shown that 3H-5-HT binding to 5-HT1A sites corresponded to that displaceable by 0.1 microM 8-OH-DPAT or 1 microM spiperone. The "non-5-HT1A" sites labeled by 3H-5-HT in the presence of 0.1 microM 8-OH-DPAT corresponded mainly to 5-HT1B sites. 5-HT1A binding was notably high in limbic regions (dentate gyrus, CA1 and CA3 hippocampal regions, lateral septum, frontal cortex), whereas 5-HT1B binding was particularly concentrated in extrapyramidal areas (caudate nucleus, globus pallidus, substantia nigra). Except in the latter regions, where only one class of 5-HT1 sites was found, both 5-HT1A and 5-HT1B sites existed in all areas examined. The selective degeneration of serotoninergic neurons produced by an intracerebral injection of 5,7-dihydroxytryptamine was associated only with a significant loss of 5-HT1A binding to the dorsal raphe nucleus (-60%) and of 5-HT1B binding to the substantia nigra (-37%). These results are discussed in relation to the possible identity of 5-HT1A and/or 5-HT1B sites with the presynaptic 5-HT autoreceptors controlling nerve impulse flow and neurotransmitter release in serotoninergic neurons.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947981      PMCID: PMC6568641     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  74 in total

1.  Regulation of 5-HT(1A) receptor-stimulated [35S]-GtpgammaS binding as measured by quantitative autoradiography following chronic agonist administration.

Authors:  J Hensler; H Durgam
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

Authors:  M Hajós; E Hajós-Korcsok; T Sharp
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 3.  CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Authors:  Karl-Erik Andersson; Rikard Pehrson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.

Authors:  G A Higgins; B J Jones; N R Oakley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 5.  The serotonin 5-HT1D receptor: a progress review.

Authors:  C Waeber; P Schoeffter; D Hoyer; J M Palacios
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

Review 6.  The 5-HT1A receptor: an overview of recent advances.

Authors:  S el Mestikawy; A Fargin; J R Raymond; H Gozlan; M Hnatowich
Journal:  Neurochem Res       Date:  1991-01       Impact factor: 3.996

7.  Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; M Verhoye; J Van Audekerke; G Vanhoutte; Andrew S Lowe; Andrew M Blamire; Thomas Steckler; A Van der Linden; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2010-11-20       Impact factor: 4.530

8.  Chronic fluoxetine selectively upregulates dopamine D₁-like receptors in the hippocampus.

Authors:  Katsunori Kobayashi; Eisuke Haneda; Makoto Higuchi; Tetsuya Suhara; Hidenori Suzuki
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

9.  (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.

Authors:  T Jolas; S Haj-Dahmane; L Lanfumey; C M Fattaccini; E J Kidd; J Adrien; H Gozlan; B Guardiola-Lemaitre; M Hamon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

10.  A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.

Authors:  Johan Lundberg; Jacqueline Borg; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2007-09-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.